ESCALON

A H2020 research collaboration between Europe and Latin America developing cost-effective tools for the early diagnosis of hepatobiliary cancers

[Jose Debes MD PhD @JoseDebesMD]

Our study @EscalonLiver on TLL1 and HCC in Latin America
https://t.co/we0D4IOuiA
@AnnalsofHepatol @MarcoArreseMD @diaz_ferrer1 @dcbalderramo @hccconnectinfo @LiverCancerConn @FundHepa

[Jose Debes MD PhD @JoseDebesMD]

Great work by @MTappataMD @Spencer_GobleMD and @EscalonLiver looking at reported ancestry and HCC in Hispanics #TLM23
Direct correlation between non-european ancestry and NAFLD as a cause of HCC (next figure)
@UMN_GIHep @UMNews @dcbalderramo @MarcoArreseMD @diaz_ferrer1

[Jose Debes MD PhD @JoseDebesMD]

Our study @EscalonLiver showing no impact of STAT4 SNP on HCC risk in Hispanics...unless they identify of European ancestry.
Key to assess ancestry!

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americanshttps://pubmed.ncbi.nlm.nih.gov/37760499/

[Jose Debes MD PhD @JoseDebesMD]

Our @EscalonLiver study validating GALAD for #HCC in Latin America and assessing ASAP score @HepCommJournal
Interesting data on non-cirrhotic HCC

Validation and optimization of AFP-based biomarkers for early HCC detection in Latin America and Europe https://t.co/W4cqE2TrFI

[Domingo Balderramo @dcbalderramo]

ALEH Day 2. Presentation from Escalon. 2 poster and 1 oral presentation @EscalonLiver

[Domingo Balderramo @dcbalderramo]

ALEH. Bogotá Day 3. Excellent presentations from ESCALON members (2 poster and 1 oral presentation) @EscalonLiver @MarcoArreseMD Jhon Prieto @belupisano

[Domingo Balderramo @dcbalderramo]

Great presentation from @EnriquEvilu1978 related to the International CCA registry & Escalon participation. #ALEH 2023 @JesusMBanales @LIzquierdoSan

[ESCALON @EscalonLiver]

Congratulations Dr. Marco Arrese! @MarcoArreseMD

[Enrique Carrera Estupiñan @EnriqCarrera]

Felicitaciones Marco!
Gran ejemplo y orgullo para Latinoamerica!

[Domingo Balderramo @dcbalderramo]

Comenzando ALEH 2023 en Bogotá con Jhon Prieto @GCastro_NarroMD @rabataller

[Enrique Carrera Estupiñan @EnriqCarrera]

TTT Colombia
Ecuador Presente!!! @heugenioespejo @USFQ_Ecuador @alehlatam @EscalonLiver

[ESCALON @EscalonLiver]

Congratulations team!

[Jose Debes MD PhD @JoseDebesMD]

Great effort by our great team to publish a great paper w/the largest cohort of NAFLD in South America!
@dcbalderramo @EscalonLiver @Jo_akambaseMD @diaz_ferrer1
Epidemiology and risk factors for histopathologic characteristics of NAFLD in South Ame… https://t.co/ycQjeUZdx3

[ESCALON @EscalonLiver]

@Cancers_MDPI @JoseDebesMD @pabloromagnoli @ErasmusMC @IucbcI Our review was selected by the Editor of the journal Cancer (MDPI)!

[Cancers MDPI @Cancers_MDPI]

🏆Check out the Editor's Choice #Review "Serum Biomarkers for the Prediction of Hepatocellular Carcinoma"

👥Authors: @JoseDebesMD, @pabloromagnoli et al. @ErasmusMC @IucbcI

🔗Link here: https://t.co/BDHi8vdZYI

[Enrique Carrera Estupiñan @EnriqCarrera]

Fighting against Hepatitis B in Sarayacu Ecuadorian Amazon. Beatiful group and great job !!@USFQ_Ecuador @EscalonLiver @NO_hep @hepatitis @heugenioespejo

[ESCALON @EscalonLiver]

Congratulations to the team Bañales!

[Jesus Bañales @JesusMBanales]

Just 🍿!😃

🍀Liquid Biopsy 🩸protein biomarkers for Cholangiocarcinoma!

🔓👉 https://t.co/T0TixwdbRK

Accurate, fast & cost-effective test to 🔍:

👉risk of CCA (PSC👫)
👉early diagnosis
👉prognosis

🩸Biomarkers 🪞tumor cells (scRNAseq)

#livertwiter

[Jose Debes MD PhD @JoseDebesMD]

Local but important work on HBV in Argentina by our awesome collaborators @belupisano & V. Re
Genotype variation between acute and chronic HBV, HIV+ & -, mutation variants and HDV
gt seems to matter!
Acute and chronic HBV infection in central Argentina: https://t.co/rVO7DqZTH8

[Jose Debes MD PhD @JoseDebesMD]

@dcbalderramo @diaz_ferrer1 @LiverCancerConn @hepatitisihelpc @FundHepa #MedTwitter

[ESCALON @EscalonLiver]

Our meeting in Chile has ended but the last year of ESCALON is about to start! #EUHorizon2020

[Kirk Wangensteen, MD/PhD @KirkWangensteen]

@EscalonLiver @JoseDebesMD @EUhorizon2020 It was an honor to present at the @EscalonLiver meeting. I am impressed by the international team that has assembled to tackle hepatobiliary cancer in South America!

[ESCALON @EscalonLiver]

And the last talk by @pabloromagnoli highlights the advances in aflatoxin measurements, immune infiltrates in NASH patients that precedes HCC and Erasmus+ interactions

[ESCALON @EscalonLiver]

Last day of our ESCALON meeting in Las Majadas, Chile.

[ESCALON @EscalonLiver]

@diaz_ferrer1 talks about Systemic Treatment and Survival of HCC patients without cirrhosis